Sign in
4

Changes in Ownership

HALOZYME THERAPEUTICS, INC. Filed Acc 0001415889-25-005311

SVP, CHIEF TECHNICAL OFFICER gave up 2,410 shares (to pay taxes)

  • SVP, CHIEF TECHNICAL OFFICER acquired 4,747 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER 2025-02-23 Option exercise +4,747 197,863 D
LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER 2025-02-23 Shares withheld for taxes −2,410 $57.75 $139,178 195,453 D
Derivatives
LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER 2025-02-23 Option exercise · Restricted Stock Units −4,747 14,238 D
Loading xslF345X05/form4-02242025_100257.xml…